FindTrial
Sign In

Pharmacodynamics of propofol in painless enteroscopy in different ages people

Pharmacodynamics of propofol in painless enteroscopy in different ages people

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016956
Enrollment
Unknown
Registered
2018-07-04
Start date
2018-07-09
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enteritis, Intestinal tumor

Interventions

super elderly patient group:Patient aged from 76 to 89 receive propofol TCI
elderly patient group:Patient aged from 65 to 75 receive propofol TCI
young patient group:Patient aged from 30 to 64 receive propofol TCI

Sponsors

Shunde Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II; 2. Aged 30-89 years; 2. Painless colonoscopy.

Exclusion criteria

Exclusion criteria: 1. Potentially difficult airway; 2. hepatic or renal dysfunction; 3. Cardiovascular disease or dysfunction of blood coagulation; 4.Nervous system disease; 5. allergy.

Design outcomes

Primary

MeasureTime frame
Body movement;—

Secondary

MeasureTime frame
The time of openning eyes;The time Leave the recovery room;MAP and HR;the usage of vascular drugs;—

Countries

China

Contacts

Public ContactChen Hanwen

Shunde Hospital, Southern Medical University

53918749@qq.com+86 13724671233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026